| Psychiatric disorders from childhood to adulthood in 22q11. 2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11. 2 Deletion Syndrome M Schneider, M Debbané, AS Bassett, EWC Chow, WLA Fung, ... American Journal of Psychiatry 171 (6), 627-639, 2014 | 722 | 2014 |
| Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11. 2 deletion) syndrome T Green, D Gothelf, B Glaser, M Debbane, A Frisch, M Kotler, A Weizman, ... Journal of the American Academy of Child & Adolescent Psychiatry 48 (11 …, 2009 | 321 | 2009 |
| International Consortium on Brain and Behavior in 22q11. 2 Deletion Syndrome. Psychiatric disorders from childhood to adulthood in 22q11. 2 deletion syndrome: results from the … M Schneider, M Debbané, AS Bassett, EW Chow, WL Fung, ... Am J Psychiatry 171 (6), 627-639, 2014 | 173 | 2014 |
| Sex differences in psychiatric disorders: what we can learn from sex chromosome aneuploidies T Green, S Flash, AL Reiss Neuropsychopharmacology 44 (1), 9-21, 2019 | 151 | 2019 |
| Risk factors and the evolution of psychosis in 22q11. 2 deletion syndrome: a longitudinal 2-site study D Gothelf, M Schneider, T Green, M Debbané, A Frisch, B Glaser, H Zilkha, ... Journal of the American Academy of Child & Adolescent Psychiatry 52 (11 …, 2013 | 130 | 2013 |
| Creatine monohydrate in resistant depression: a preliminary study S Roitman, T Green, Y Osher, N Karni, J Levine Bipolar Disorders 9 (7), 754-758, 2007 | 130 | 2007 |
| Genotype-phenotype correlation in 22q11. 2 deletion syndrome E Michaelovsky, A Frisch, M Carmel, M Patya, O Zarchi, T Green, ... BMC medical genetics 13, 1-11, 2012 | 116 | 2012 |
| The effect of methylphenidate on prefrontal cognitive functioning, inattention, and hyperactivity in velocardiofacial syndrome T Green, R Weinberger, A Diamond, M Berant, L Hirschfeld, A Frisch, ... Journal of Child and Adolescent Psychopharmacology 21 (6), 589-595, 2011 | 52 | 2011 |
| Elucidating X chromosome influences on attention deficit hyperactivity disorder and executive function T Green, SB Shrestha, LC Chromik, K Rutledge, BF Pennington, DS Hong, ... Journal of Psychiatric Research 68, 217-225, 2015 | 49 | 2015 |
| Phenotypic psychiatric characterization of children with Williams syndrome and response of those with ADHD to methylphenidate treatment T Green, S Avda, I Dotan, O Zarchi, L Basel‐Vanagaite, G Zalsman, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 159 …, 2012 | 48 | 2012 |
| Schizophrenia-like neurophysiological abnormalities in 22q11. 2 deletion syndrome and their association to COMT and PRODH genotypes O Zarchi, M Carmel, C Avni, J Attias, A Frisch, E Michaelovsky, M Patya, ... Journal of psychiatric research 47 (11), 1623-1629, 2013 | 45 | 2013 |
| Escitalopram in the treatment of patients with schizophrenia and obsessive–compulsive disorder: an open-label, prospective study R Stryjer, Y Dambinsky, I Timinsky, T Green, M Kotler, A Weizman, ... International clinical psychopharmacology 28 (2), 96-98, 2013 | 44 | 2013 |
| The effectiveness and safety of antipsychotic and antidepressant medications in individuals with 22q11. 2 deletion syndrome N Dori, T Green, A Weizman, D Gothelf Journal of Child and Adolescent Psychopharmacology 27 (1), 83-90, 2017 | 36 | 2017 |
| A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: Velocardiofacial (22q11. 2 deletion) and Williams (7q11. 23 deletion … O Zarchi, A Diamond, R Weinberger, D Abbott, M Carmel, A Frisch, ... European Psychiatry 29 (4), 203-210, 2014 | 36 | 2014 |
| Hemisphere asymmetry in schizophrenia as revealed through line bisection, line trisection, and letter cancellation AZ Zivotofsky, S Edelman, T Green, L Fostick, RD Strous Brain Research 1142, 70-79, 2007 | 32 | 2007 |
| The sixth international RASopathies symposium: precision medicine—from promise to practice KW Gripp, L Schill, L Schoyer, B Stronach, AM Bennett, S Blaser, A Brown, ... American Journal of Medical Genetics Part A 182 (3), 597-606, 2020 | 30 | 2020 |
| Aberrant parietal cortex developmental trajectories in girls with turner syndrome and related visual–spatial cognitive development: A preliminary study T Green, LC Chromik, PK Mazaika, K Fierro, MM Raman, LC Lazzeroni, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165 …, 2014 | 30 | 2014 |
| Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11. 2DS subjects M Carmel, O Zarchi, E Michaelovsky, A Frisch, M Patya, T Green, ... Journal of psychiatric research 56, 28-35, 2014 | 30 | 2014 |
| Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs—an open-label study R Stryjer, D Budnik, T Ebert, T Green, L Polak, S Weizman, B Spivak Clinical neuropharmacology 37 (3), 79-81, 2014 | 30 | 2014 |
| Attention deficit hyperactivity disorder (ADHD) in phenotypically similar neurogenetic conditions: Turner syndrome and the RASopathies T Green, PE Naylor, W Davies Journal of Neurodevelopmental Disorders 9, 1-12, 2017 | 28 | 2017 |
Allan ReissProfessor of Psychiatry, Stanford UniversityVerified email at stanford.edu
